The Effect of the Use of Peanut Ball on Labor Time in Nulliparous Women

This is a randomized control study. Each patient who meets the inclusion criteria will be informed about the study within 12 hours of admission to the unit. When the participant is alert and prior to administration of medicinal pain relief measures, the patient will be asked to consent to be a participant. Basic admission demographic information will be collected from the electronic medical record (EMR) and will be used to identify potential subjects (inclusion/exclusion criteria). Recruitment will include a scripted informative conversation with the potential subject along with an informed consent to further determine eligibility and willingness to participate in the study.

The peanut ball size will be determined by the patient weight indicated on the peanut ball itself and compared with the patient's documented weight in the EMR. The ball will be inflated prior to use and a pictorial introduction of how to use the peanut ball will be shown to the study subject.

The peanut ball use will be discontinued immediately prior to the delivery of the baby. The study time will be documented and calculated for all subjects (treatment and control) from the time of introduction of epidural analgesia to the delivery of the baby.

The proposed Peanut Ball manufactured by Clinton industries at graylinemedical.com is made from durable, ribbed, heavy-walled, polyvinyl chloride (PVC) material, burst resistant, deflate slowly if punctured, and latex free with non-slip grip ridges. It is available in variable sizes ranging from 40 cm-70 cm in length. It is re-usable, after cleaning with hospital grade wipes. It is recommended that the peanut balls should be protected from sunlight and sharp objects.

Inclusion criteria

Women between 18 -50 years of age presenting in labor or for induction of labor

• Nulliparous (first delivery)
• 37 0/7- 41 6/7 weeks of gestation
• Singleton, Vertex presentation
• Plan to deliver with epidural anesthesia
• Has had at least one vaginal exam to determine the cervical dilatation prior to the proposed intervention
• Prescribed Oxytocin (Pitocin)

Exclusion criteria

• Multi gravida women
• Admitted in second stage of labor
• Multiple gestations
• Non-vertex presentations
• Women receiving magnesium sulfate
• Preterm or post term labor (<37 weeks or >42 weeks)
• Women with hypertensive disorders of pregnancy
• Diabetes including gestational diabetes
• Muscular or skeletal limitations that does not allow for positioning
• Un-medicated labors ( delivery without epidural, about 5-20% )
• Category III fetal heart rate tracings
• Suspected infections (e.g. STDs, viral/bacterial infections)
• Planned cesarean delivery